SVG
Antimicrobial Resistance (AMR)
Antimicrobial resistance (AMR) has been called the silent pandemic. FasterCures seeks to encourage the development of new antibiotics by promoting policies that could incentivize drug developers, investigate ways to bring more private capital into the space, and highlight emerging approaches to treating bacterial infections beyond antibiotics.
Antimicrobial Resistance (AMR)
Related Articles
-
Models for Financing Antibiotic Development to Address Antimicrobial Resistance
The Financial Innovations Labs® and FasterCures teams have collaborated on a project to identify new models for financing the antimicrobial resistant antibiotic pipeline. These past 18 months have demonstrated how consequential public...Read Report
Related Videos
-
A Global Priority: The Fight Against Antimicrobial Resistance2023 Future of Health Summit Session Part 1 -
A Conversation with US Senators Michael Bennet, Colorado and Todd Young, Indiana2023 Future of Health Summit Session Part 2 -
What’s Next for the UK’s Subscription Model in the Fight Against Antimicrobial Resistance2023 FasterCures Webinar -
Reviving the Antibiotic Pipeline: How Can New Investments and Incentives Beat Superbugs?2021 Global Conference Session -
Are Resistant Infections the Next Pandemic? New Antibiotics Need New Incentives2020 Future of Health Summit Session -
Superbugs: Avoiding an Existential Threat to Humanity2018 London Summit Session